Clinical Trials Logo
  1. Home
  2. Von Hippel-Lindau Disease
  3. NCT00052013

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Von Hippel-Lindau Disease Clinical Trial

Official title:
A Phase II Open-Label Study of Oral, Continuous, Once Daily PTK787/ZK 222584 in Patients With Von Hippel-Lindau Disease (VHL) and Hemangioblastoma (HB)

Clinical Trial Summary

The purpose of this study is to determine whether PTK787/ZK 222584 is effective in treating hemangioblastoma of the brain and/or retina in patients with von Hippel-Lindau disease. The study will also assess safety and tolerability of PTK787/ZK 222584, and changes in markers of angiogenesis (new blood vessel growth).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00052013
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 2
Start date February 2003
View Details
See also
  Status Clinical Trial Phase
Completed NCT00970970 - Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease N/A
Not yet recruiting NCT05737602 - Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease N/A
Recruiting NCT05810246 - 68Ga-NY104 PET/CT in Von Hippel-Lindau Disease Phase 2
Completed NCT01168440 - Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease Phase 2
Recruiting NCT06194669 - Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
Recruiting NCT04074135 - Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors Phase 2
Enrolling by invitation NCT03979833 - Drivers of Hypoxia-induced Angiogenesis in Tumor Development
Active, not recruiting NCT04458935 - Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma
Recruiting NCT03749980 - MyVHL: Patient Natural History Study
Recruiting NCT05424016 - Propranolol and Von Hippel-Lindau Disease N/A
Recruiting NCT02420067 - Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients N/A
Recruiting NCT04924075 - Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) Phase 2
Recruiting NCT03050268 - Familial Investigations of Childhood Cancer Predisposition
Completed NCT02108002 - Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only) Phase 1
Not yet recruiting NCT05843305 - A Study of BPI-452080 in Subjects With Solid Tumors Phase 1
Completed NCT03108066 - PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma Phase 2
Completed NCT00062166 - Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease